Genfit - ADR
NASDAQ:GNFT 11:17:14 AM EDT
| Market Cap (Intraday) | 191.53M |
| Current PE | 127.10 |
| Forward PE | 3.35 |
| 2yr Forward PE | N/A |
| 10-Day MA | $3.84 |
| 50-Day MA | $4.09 |
| 200-Day MA | $4.20 |
Genfit - ADR Stock, NASDAQ:GNFT
Parc Eurasante, 885, Avenue Eug��ne Avin�©e, Loos, Hauts-de-France 59120
France
Phone: +33.3.20.16.40.00
Number of Employees: 159
Description
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver. The company was founded by Jean-Fran�§ois Mouney, Florence S�©journ�©, and Bart Staels in September 1999 and is headquartered in Loos, France.